This study is an Investigator-initiated, placebo-controlled, multicenter noninferiority
trial, comparing rapid termination of systemic glucocorticoid treatment with a tapering
regime over 4 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborators:
HEMMI Stiftung Switzerland Kantonsspital Baselland Bruderholz Swiss National Science Foundation